These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12496253)

  • 81. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX.
    Christiansen WT; Castellino FJ
    Biochemistry; 1994 May; 33(19):5901-11. PubMed ID: 8180219
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cleavage and activation of human factor IX by serine proteases.
    Enfield DL; Thompson AR
    Blood; 1984 Oct; 64(4):821-31. PubMed ID: 6383497
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The insect salivary protein, prolixin-S, inhibits factor IXa generation and Xase complex formation in the blood coagulation pathway.
    Isawa H; Yuda M; Yoneda K; Chinzei Y
    J Biol Chem; 2000 Mar; 275(9):6636-41. PubMed ID: 10692472
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of residues in the Gla-domain of human factor IX involved in the binding to conformation specific antibodies.
    Wojcik EG; Cheung WF; van den Berg M; van der Linden IK; Stafford DW; Bertina RM
    Biochim Biophys Acta; 1998 Jan; 1382(1):91-101. PubMed ID: 9507074
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Activation of factor IX by factor XIa.
    Gailani D
    Trends Cardiovasc Med; 2000 Jul; 10(5):198-204. PubMed ID: 11282295
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The roles of factor VII's structural domains in tissue factor binding.
    Chang JY; Stafford DW; Straight DL
    Biochemistry; 1995 Sep; 34(38):12227-32. PubMed ID: 7547964
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.
    Braunstein KM; Noyes CM; Griffith MJ; Lundblad RL; Roberts HR
    J Clin Invest; 1981 Dec; 68(6):1420-6. PubMed ID: 6976355
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.
    Imamura T; Tanase S; Hamamoto T; Potempa J; Travis J
    Biochem J; 2001 Jan; 353(Pt 2):325-31. PubMed ID: 11139397
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.
    Sinha D; Seaman FS; Walsh PN
    Biochemistry; 1987 Jun; 26(13):3768-75. PubMed ID: 3498513
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intrinsic versus extrinsic coagulation. Kinetic considerations.
    Warn-Cramer BJ; Bajaj SP
    Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
    Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
    Biochemistry; 2015 Jun; 54(24):3814-21. PubMed ID: 26023895
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A sequential mechanism for exosite-mediated factor IX activation by factor XIa.
    Geng Y; Verhamme IM; Messer A; Sun MF; Smith SB; Bajaj SP; Gailani D
    J Biol Chem; 2012 Nov; 287(45):38200-9. PubMed ID: 22961984
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The N-terminal epidermal growth factor-like domain of coagulation factor IX. Probing its functions in the activation of factor IX and factor X with a monoclonal antibody.
    Persson KE; Villoutreix BO; Thämlitz AM; Knobe KE; Stenflo J
    J Biol Chem; 2002 Sep; 277(38):35616-24. PubMed ID: 12105230
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium.
    Agah S; Bajaj SP
    J Thromb Haemost; 2009 Aug; 7(8):1426-8. PubMed ID: 19500239
    [No Abstract]   [Full Text] [Related]  

  • 98. A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
    Miller TN; Sinha D; Baird TR; Walsh PN
    Biochemistry; 2007 Dec; 46(50):14450-60. PubMed ID: 18020374
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Regulation of the tertiary structure and function of coagulation factor IX by magnesium (II) ions.
    Sekiya F; Yamashita T; Atoda H; Komiyama Y; Morita T
    J Biol Chem; 1995 Jun; 270(24):14325-31. PubMed ID: 7782291
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.
    Neels JG; van Den Berg BM; Mertens K; ter Maat H; Pannekoek H; van Zonneveld AJ; Lenting PJ
    Blood; 2000 Nov; 96(10):3459-65. PubMed ID: 11071642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.